Quantcast

Latest Sirolimus Stories

2014-05-15 16:28:10

-- Oral Presentations to Include New Long-Term Results from First-in-Human Study -- DURHAM, N.C., May 15, 2014 /PRNewswire/ -- Micell Technologies, Inc. today announced the updated three- and two-year clinical outcomes from its DESSOLVE I and II clinical trials, respectively, will be presented at the EuroPCR conference to be held in Paris, France from May 20 - 23. Two oral presentations will be made by William Wijns, M.D., Ph.D., Cardiovascular Center, Aalst, Belgium: -- DESSOLVE II...

2014-04-28 23:04:36

Findings Show Several FDA-Approved Drugs May also be Effective in Patients Diagnosed with Dilated Cardiomyopathy New York, NY (PRWEB) April 28, 2014 Scientists at Icahn School of Medicine at Mount Sinai, along with collaborators at institutions in India, Italy, and Japan, have identified the first gene linked to childhood-onset familial dilated cardiomyopathy (DCM), one of the most common heart muscle diseases in children. It is a progressive and potentially fatal heart condition...

2014-04-03 12:58:10

New research suggests that drugs commonly used to prevent organ rejection after transplantation may also be helpful for combating HIV. The findings, which are published in the American Journal of Transplantation, suggest a new strategy in the fight against HIV and AIDS. Despite the effectiveness of antiviral therapies at suppressing HIV, the virus still persists indefinitely at low levels in infected patients who are diligent about taking their medications. "Current therapies fail to cure...

2014-03-28 08:27:19

Post-Market Registry to Evaluate Long-Term Safety and Performance in Routine Practice HONG KONG, March 28, 2014 /PRNewswire/ -- OrbusNeich today announced the completion of enrollment in the prospective, multicenter, all-comers REMEDEE Registry (Multicenter, Prospective, Clinical Outcomes After Deployment of the Abluminal Sirolimus Coated Bio-Engineered Stent (Combo Bio-Engineered Sirolimus Eluting Stent) Post Market Registry) to evaluate the COMBO Stent for the treatment of coronary...

2014-03-05 12:27:46

-- Rapid polymer absorption within three months coupled with drug delivery profile up to nine months provides for excellent healing -- DURHAM, N.C., March 5, 2014 /PRNewswire/ --- Micell Technologies, Inc. today announced that the long-term clinical outcomes from the DESSOLVE I and II clinical trials recently were presented at the Cardiovascular Research Technologies (CRT) Conference held in Washington, D.C., February 22 - 25. The data presentation, "MiStent SES Clinical Program:...

2014-01-04 23:01:12

Scientists in Japan and Austria say the kinase inhibitor temsirolimus stops mesothelioma growth in two different ways. Raleigh, NC (PRWEB) January 04, 2014 A new study published in the journal Oncology Reports and detailed by Surviving Mesothelioma suggests that temsirolimus, a kinase inhibitor used to treat advanced renal cell carcinoma (RCC), may offer a promising new way to treat malignant pleural mesothelioma. The group studied temsirolimus by itself and in combination with the...

Study Reveals Protein That Keeps People And Their Skeletons Organized
2013-11-14 10:34:42

University of Southern California Most people think that their planners or their iPhones keep them organized, when proteins such as liver kinase b1 (Lkb1) actually have a lot more to do with it. New research from postdoctoral fellow Lick Lai in the lab of USC scientist Andy McMahon published in Proceedings of the National Academy of Sciences (PNAS) sheds light on how this important protein keeps people organized on a basic level by promoting orderly skeletal growth and preventing skeletal...

Genetic Pathway Could Be New Target For Pediatric Tumor Treatment
2013-11-07 11:27:12

redOrbit Staff & Wire Reports - Your Universe Online Low-grade gliomas – a type of pediatric brain tumor that is difficult to care for medically – could potentially be treated using a known genetic pathway, according to new research published in Thursday’s edition of the journal Neuro-Oncology. In laboratory studies, Dr. Fausto Rodriguez, assistant professor of pathology and oncology at Johns Hopkins, and colleagues reported that the mammalian target of the rapamycin (mTOR)...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.